von Tobias Borgers | Mrz 15, 2021 | Frewitt
Pharmaceutical Granulators COVID-19 Market Effect The COVID-19 outbreak has had a major effect on the Pharmaceutical Granulators market, according to market reports. Limits that result in operators dominating the hospitality industry in the low-sales sector are also...
von Tobias Borgers | Feb 27, 2021 | Frewitt
Gilead Sciences has completed the previously announced acquisition of cancer therapies developer Immunomedics for approximately $21bn. In September, Gilead signed a definitive merger agreement to acquire all the outstanding shares of Immunomedics at a price of $88 per...
von Tobias Borgers | Jan 25, 2021 | Frewitt
There are several factors at play that explain this reticence to accept change in the pharma industry. For one, regulatory overhead is high and some organisations are reluctant to take on risk. Changing processes means re-evaluating challenges, and there are...
von Tobias Borgers | Okt 29, 2020 | Frewitt
“ The report titled Global Pin Mills Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Pin Mills market. The market analysts...
von Tobias Borgers | Okt 21, 2020 | Frewitt
Global Granulator for Pharmaceutical Market Report 2020- Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Granulator for Pharmaceutical industry. The report also covers segment data, including: type...
von Tobias Borgers | Sep 24, 2020 | Frewitt
US-based pharmaceutical company Merck, known as MSD in Europe, is set to build a $1.3bn (£1bn) research hub on a 25,000m2 site in London, England, UK. Originally announced in 2017, the project has been delayed due to difficulties in finding space in London, as well as...
